Related Experiment Video
Updated: Apr 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Childhood cancer survival rates in two South African units
David K Stones1, Gerhard P De Bruin, Tonya M Esterhuizen
1Department of Paediatrics and Child Health, Universitas Academic Hospital Complex, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. stonesDK@ufs.ac.za.
Insights
Childhood cancer survival rates in South Africa were 52.1%, lower than in developed countries. This is due to late diagnosis, highlighting the need for improved cancer awareness strategies.
Area of Science:
- Pediatric Oncology
- Cancer Epidemiology
- Global Health
Background:
- Childhood cancer cure rates are high globally, but survival varies significantly between developed and developing nations.
- Survival data for childhood cancers in many African countries remain largely unknown.
- Significant disparities exist in childhood cancer outcomes worldwide.
Purpose of the Study:
- To analyze and report on childhood cancer survival rates.
- To compare outcomes between two major South African pediatric oncology centers.
- To identify factors influencing survival in South African children with cancer.
Main Methods:
- Retrospective review of pediatric cancer patients (0-15 years) admitted between 1987 and 2011.
- Inclusion of data from two South African pediatric oncology units: Universitas Hospital and Tygerberg Hospital.
- Histological confirmation of all diagnoses and similar treatment protocols across units.
Main Results:
- Overall survival rate for childhood cancers was 52.1% across 3,241 children.
- Leukemia (25.0%), brain tumors (19.5%), and lymphoma (13.0%) were the most common malignancies.
- Lymphoma (63.9%) and nephroblastoma (62.6%) showed the highest survival, while brain tumors had the lowest (46.4%).
- Survival rates varied by ethnicity: White (62.8%), mixed-race (53.8%), and Black children (48.5%).
Conclusions:
- South African childhood cancer survival rates are lower than in developed countries, primarily due to advanced disease at presentation.
- Urgent implementation of new strategies to improve cancer awareness is critical.
- Addressing late diagnosis is essential to improve pediatric cancer outcomes in South Africa.
Introduction:
Childhood cancer is relatively rare, but there is a very good chance of cure. While overall survival rates of >70% are reported from developed countries, survival is much less likely in developing countries and unknown in many countries in Africa.
Objective:
To analyse survival rates of childhood cancers in two South African paediatric oncology units.
Methods:
This retrospective review included all children (0 - 15 years) admitted with a malignancy at two paediatric oncology units (Universitas Hospital Academic Complex in Bloemfontein, Free State, and Tygerberg Hospital in Cape Town, Western Cape) between 1987 and 2011. The protocols used in the units were similar, and all the diagnoses were confirmed histologically.
Results:
There were 3 241 children, 53.5% of whom were males. Median follow-up was 17 months. The most common cancers were leukaemia (25.0%), brain tumours (19.5%), lymphoma (13.0%) and nephroblastoma (10.0%). The prevalences of neuroblastoma and retinoblastoma were similar at 5.8% and 5.7%, respectively. Overall survival was calculated to be 52.1%. Lymphoma and nephroblastoma had the highest survival rates at 63.9% and 62.6%, respectively. Brain tumours had the lowest survival rate at 46.4%. A comparison between ethnic groups showed white children to have the highest survival rate (62.8%); the rate for children of mixed racial origin was 53.8% and that for black children 48.5%.
Conclusions:
Overall survival rates for children admitted to two paediatric cancer units in South Africa were lower than data published from developed countries, because many children presented with advanced disease. New strategies to improve cancer awareness are urgently required.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Comparing the Survival Analysis of Two or More Groups
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer

